Clinical Trial Update: Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating FOLFIRI with or without bevacizumab in patients after surgery for stage II/III colon cancer; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma
• Colon Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Fluorouracil, Leucovorin, and Oxaliplatin (FOLFIROX/FOLFIRI-like regimen)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7 | Phase 3 | Status: COMPLETED | Results posted: 2012-12-03